Russia's Health Ministry said on Wednesday that clinical trials of a COVID-19 vaccine have been initiated in the country, as reported This is Money.
Liquid and powder forms of the vaccine developed by the Moscow-based Gamaleya research institute will be tested on two groups of volunteers, 38 people each, the ministry said.
"All potential participants of the trial ... spent two weeks (quarantined) in a sanatorium for observation," the ministry said, adding that the first injections are scheduled for June 18 and June 19.
According to Russian media, at least seven research facilities in the country are developing COVID-19 vaccines.
To read more NewsPoints articles, click here.